Showing results (1381-1390 of 1,400) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|June 12, 2026
Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020)Alessandro Leonetti, Monica Pluchino, Roberta Minari, et al.
JCO Precision Oncology|November 9, 2023
Parent Quality of Life After Disclosure of Pediatric Oncology Germline Sequencing ResultsKatianne M Howard Sharp, Chen Li, Zhaohua Lu, et al.
JCO Precision Oncology|June 17, 2026
Validation of the Transcription Association Chromosomal Instability Index Biomarker on RNA Sequencing in Soft Tissue SarcomasAtaaillah Benhaddou, Gaëlle Pérot, Philippe Rochaix, et al.
JCO Precision Oncology|July 1, 2026
Cell-Free DNA Analysis With Clinicopathologic Factors for Early Detection and Refining Lymph Node Metastasis Risk in T1 Colorectal Cancer: Results From the COSMOS-CRC StudyTatsuro Murano, Hiroaki Ikematsu, Nobuhisa Matsuhashi, et al.
JCO Precision Oncology|July 6, 2026
Time to Treatment Failure as an End Point in Pragmatic Oncology Trials: Association With Progression-Free Survival Across Randomized StudiesJanene Dalrymple, Rebecca Symons, Katrin M Sjoquist, et al.
JCO Precision Oncology|June 18, 2026
Diagnostic Accuracy and Concordance of Self-Collected Cervical CDO1 and CELF4 Methylation Testing Compared With Physician Sampling for Endometrial Cancer DetectionPeixuan He, Yishan Wang, Nian Xie, et al.
JCO Precision Oncology|July 8, 2026
Development and Validation of a Cytochrome C Oxidase Subunit 6B2-Based Risk Model for Cholangiocarcinoma RecurrenceMeiru Chen, Xiaoli Xie, Jiaqi Wang, et al.
JCO Precision Oncology|July 8, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision OncologySophia C Kamran, Monica Borges, Jeff Michalski, et al.
JCO Precision Oncology|July 15, 2026
Hypoalbuminemia as a Predictive Biomarker of Dyspnea Response to Dexamethasone and Placebo in Patients With Cancer: Secondary Analysis of the ABCD Randomized Clinical TrialDavid Hui, Kristofer Jennings, Amy Ontai, et al.
JCO Precision Oncology|July 15, 2026
Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary CohortsOmar Carranza, Shubham Pant, Martin Schuler, et al.
Pageof 140